A new method to improve cancer biobanking for better access and analysis.
Official title: A Novel Multi-analyte Approach to Democratize Cancer Biobanking
Funded at Ge Medical Systems Information Technologies, INC · NIH-11064179 · Data updated 2026-11-12
This study is working on a new, easier way to collect and analyze cancer samples from tumors, which will help more hospitals and communities, especially those that have been overlooked in cancer research, to participate in finding better ways to detect and treat cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ge Medical Systems Information Technologies, INC NIH-funded |
| Lab location | 1 site (Niskayuna, United States) |
| Project start | April 1, 2025 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $440,287 |
| NIH project number | 1R33CA297922-01 |
| Project ID | NIH-11064179 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients from diverse backgrounds, particularly those from lower socioeconomic groups who may have limited access to traditional biobanking resources.
✕Less likely to help
Patients who are not diagnosed with cancer or those who do not have access to participating institutions may not benefit from this research.
What this research studies
This research aims to create a simpler and more accessible way to collect and analyze cancer samples by extracting DNA, RNA, and protein from tumor touch imprints. Traditional methods of biobanking require significant resources and expertise, which can limit participation from smaller institutions and underrepresented populations. By using a technique that allows for the simultaneous extraction of multiple analytes from small samples, this project seeks to enhance the availability of cancer specimens for research and improve early detection and treatment options. The goal is to make biobanking more equitable and effective, particularly for communities that have been historically disenfranchised in cancer research.
Why it matters
Potential benefit: If successful, this research could lead to more equitable access to cancer biobanking, improving early detection and treatment for diverse populations.
How similar studies have gone: Previous research has shown success in using simplified biobanking techniques, but this specific multi-analyte approach is relatively novel.
Where this research is happening
-
Ge Medical Systems Information Technologies, INC
Niskayuna, United States Active
Researchers
- Principal investigator: Davis, Brian Michael — Ge Medical Systems Information Technologies, INC
- Study coordinator: Davis, Brian Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.